Elevance Health, Inc. Common Stock (ELV) stock analysis
ELV · Elevance Health, Inc. Common Stock
Latest recorded price: USD 446.47
Model-estimated fair value: USD 399.77. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Healthcare Plans
At $446.47, ELV trades 11.7% above the model's base-case value of $399.77. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $321.64 in the conservative case and $490.93 in the optimistic case, with a valuation confidence score of 83/100. About 73% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 8.3%, free cash flow margin 1.6%, ROIC 14.6%. The model flags 1 risk signal for this company.